Home
/
Pyxis Oncology, Inc.
/
Financials
/
Quarterly
Pyxis Oncology, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Pyxis Oncology, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.82M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$2.82M
Aug 14, 2025
Q3
2025
Sep 30, 2024
$16.15M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$16.15M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$16.15M
May 15, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.00M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($18.35M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($21.16M)
May 15, 2025
Q2
2025
Mar 31, 2025
($21.16M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($21.20M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($17.30M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.26M)
May 15, 2025
Q2
2025
Mar 31, 2024
($3.26M)
Aug 14, 2025
Q3
2024
Sep 30, 2023
($23.05M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($15.90M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($19.24M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($19.24M)
May 14, 2024
Q3
2023
Sep 30, 2022
($27.67M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($25.56M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($31.38M)
May 11, 2023
Q2
2023
Mar 31, 2022
($31.38M)
Aug 11, 2023
Q3
2022
Sep 30, 2021
($14.18M)
Nov 1, 2022
Q3
2021
Jun 30, 2021
($8.00M)
Nov 15, 2021
Q2
2022
Jun 30, 2021
($8.15M)
Aug 15, 2022
Q3
2021
Mar 31, 2021
($36.97M)
Nov 15, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($23.46M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($19.75M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($22.91M)
May 15, 2025
Q3
2025
Sep 30, 2024
($23.75M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($20.03M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($5.61M)
May 15, 2025
Q3
2024
Sep 30, 2023
($25.35M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($18.12M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($20.95M)
May 14, 2024
Q3
2023
Sep 30, 2022
($28.39M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($25.73M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($31.39M)
May 11, 2023
Q3
2022
Sep 30, 2021
($11.62M)
Nov 1, 2022
Q2
2022
Jun 30, 2021
($5.94M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($35.73M)
May 13, 2022
Q3
2021
Sep 30, 2020
($3.19M)
Nov 15, 2021